A detailed history of Virtu Financial LLC transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 12,309 shares of INZY stock, worth $36,065. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,309
Holding current value
$36,065
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$4.31 - $6.0 $53,051 - $73,854
12,309 New
12,309 $64,000
Q4 2023

Feb 26, 2024

BUY
$2.71 - $4.5 $43,793 - $72,720
16,160 Added 153.64%
26,678 $114,000
Q3 2023

Nov 14, 2023

BUY
$4.09 - $7.0 $43,018 - $73,626
10,518 New
10,518 $44,000
Q1 2023

May 01, 2023

BUY
$1.3 - $5.73 $61,093 - $269,281
46,995 New
46,995 $269,000
Q2 2022

Aug 09, 2022

BUY
$3.2 - $5.96 $35,772 - $66,626
11,179 New
11,179 $53,000

Others Institutions Holding INZY

About Inozyme Pharma, Inc.


  • Ticker INZY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,145,700
  • Market Cap $118M
  • Description
  • Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...
More about INZY
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.